Company Announcements

Grant of Share Options

Source: RNS
RNS Number : 4069K
Craneware plc
21 April 2020
 

 

Craneware plc

("Craneware" or the "Company")

 

Grant of Share Options

 

21 April 2020 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, announces that on 20 April 2020, under the terms of the Craneware plc SAYE Option Plan (2018) ("the Option Plan"), share options (the "Options") to acquire ordinary shares of 1p each in the Company ("Shares") were granted to two Directors of the Company as follows: 

 

Director

Savings term

No. of Shares over which Options granted under the Option Plan

Percentage of issued share capital

Keith Neilson (CEO)

3 years

1,568

0.006%

Craig Preston (CFO)

3 years

1,568

0.006%

 

The Option Plan is a UK all employee HMRC approved Save As You Earn option scheme. The Options were granted on the same terms as other UK employees who chose to participate in the Option Plan. The Options have been granted at an exercise price of £11.475 per Share. The Options will ordinarily become exercisable for a period of six months from the end of the savings term.

 

PDMR notification: Keith Neilson

 

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Keith Neilson

 

2.   Reason for the notification

a) Position / status                                            CEO

b) Initial notification / Amendment                     Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument                                                         Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code                                         ISIN GB00B2425G68

 

c) Nature of the transaction                               Grant of share option under the Craneware plc

                                                                           SAYE Option Plan (2018)

 

d) Price(s) and volume(s)                                   Volume(s) granted 1,568, Exercise Price(s) £11.475

 

e) Aggregated information:                                 N/A (single transaction)

                                    i. Aggregated volume        -

                                    ii. Price                              -

 

f) Date of the transaction                                    2020-04-20

 

g) Place of the transaction                                 Outside a trading venue

 

PDMR notification: Craig Preston

 

1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Craig Preston

 

2.   Reason for the notification

a) Position / status                                             CFO

b) Initial notification / Amendment                      Initial notification

 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05

 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a) Description of the financial instrument, type of

instrument                                                         Ordinary shares of 1p each in the capital of Craneware plc

 

b) Identification code                                         ISIN GB00B2425G68

 

c) Nature of the transaction                               Grant of share option under the Craneware plc

                                                                           SAYE Option Plan (2018)

 

d) Price(s) and volume(s)                                   Volume(s) granted 1,568, Exercise Price(s) £11.475

 

e) Aggregated information:                                 N/A (single transaction)

                                    i. Aggregated volume               

                                    ii. Price                                    

 

f) Date of the transaction                                   2020-04-20

 

g) Place of the transaction                                 Outside a trading venue

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt (NOMAD & Joint Broker)               

Investec Bank (Joint Broker)

Alma (Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0205

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Andrew Clark

Sebastian Lawrence

Henry Reast

Hilary Buchanan

Helena Bogle

 

 

 

 

 

 

 

 

 

About Craneware

 

Craneware (AIM: CRW.L), the leader in automated value cycle solutions, collaborates with U.S. healthcare providers to plan, execute and monitor value-based economic performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 350 staff. Craneware's value cycle management suite includes charge capture, strategic pricing, patient engagement, claims analytics, revenue recovery and retention, and cost and margin intelligence solutions.

 

Learn more at www.craneware.com

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQFLFLBZLBBBB